ImmunoPrecise Antibodies (NASDAQ:IPA) reported quarterly sales of $4.70 million which beat the analyst consensus estimate of $4.02 million by 16.92 percent. This is a 25.87 percent increase over sales of $3.73 million the same period last year.
Microsoft’s Vision For Xbox: Next-Gen Consoles By 2028, Mid-Gen Refresh In 2024
Microsoft Corporation (NASDAQ: MSFT) plans to release successors to the Xbox Series X and Xbox Series S consoles by 2028.
